DOW JONES27,081.36-879.44 -3.15%
S&P 5003,128.21-97.68 -3.03%
NASDAQ8,965.61-255.67 -2.77%

Baird Downgrades Tandem Diabetes Care to Neutral, Raises Price Target to $75

Baird analyst Jeff Johnson downgrades Tandem Diabetes Care (NASDAQ:TNDM) from Outperform to Neutral and raises the price target from $71 to $75.

Benzinga · 02/04/2020 10:33

Baird analyst Jeff Johnson downgrades Tandem Diabetes Care (NASDAQ:TNDM) from Outperform to Neutral and raises the price target from $71 to $75.